Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)
NCT ID: NCT01348399
Last Updated: 2018-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2011-04-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
NCT01605721
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869
Evaluation of Effectiveness and Safety of the GENOUS STENT (IRIS-GENOUS STEMI)
NCT01348373
The IRIS-Resolute Integrity (IRIS-Integrity)
NCT01392846
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
XIENCE PRIME stents
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria
* Terminal illness with life expectancy \<1 year
* Patients presented with cardiogenic shock
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Abbott
INDUSTRY
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seung-Jung Park, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Ki Bae Seung, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul St. Mary's Hospital, Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Soonchunhyang Univ. Bucheon Hospital
Bucheon-si, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Gangwon National Univ. Hospital
Chuncheon, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, , South Korea
Gangneung Asan Hospital
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
National Health Insurance Corporation Ilsan Hospital
Ilsan, , South Korea
Presbyterian Medical Center
Jeonju, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Kwangju Christian Hospital
Kwangju, , South Korea
Inje University Pusan Paik Hospital
Pusan, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Pusan National University Yangsan Hospital
Pusan, , South Korea
Bundang Cha Medical Center
Seongnam, , South Korea
Asan Medical Center
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Kangnam Sacred Heart Hospital
Seoul, , South Korea
Korea University Anam Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Kyunghee University Hospital at Gangdong
Seoul, , South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, , South Korea
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, , South Korea
St.carollo Hospital
Suncheon, , South Korea
The Catholic University of Korea St. Vincent's Hospital
Suwon, , South Korea
The Catholic University of Korea Uijeongbu St. Mary's Hospital
Uijeongbu-si, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVRF2011-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.